Warning: The NCBI web site requires JavaScript to function. more...
How does endothelial cell injury start? The role of endothelin in systemic sclerosis.
Abraham D, Distler O.
Arthritis Res Ther. 2007;9 Suppl 2:S2. Review.
Related citations
Mechanisms of vascular damage in SSc--implications for vascular treatment strategies.
Guiducci S, Distler O, Distler JH, Matucci-Cerinic M.
Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v18-20. Review.
Statins and the vasculopathy of systemic sclerosis: potential therapeutic agents?
Derk CT, Jimenez SA.
Autoimmun Rev. 2006 Jan;5(1):25-32. Epub 2005 Aug 19. Review.
Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma.
Shiwen X, Leask A, Abraham DJ, Fonseca C.
Eur J Clin Invest. 2009 Jun;39 Suppl 2:19-26. Review. Erratum in: Eur J Clin Invest. 2009 Jul;39(7):630.
Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis.
Yamaguchi Y, Okazaki Y, Seta N, Satoh T, Takahashi K, Ikezawa Z, Kuwana M.
Arthritis Res Ther. 2010;12(6):R205. Epub 2010 Nov 4.
Overview of pathogenesis of systemic sclerosis.
Abraham DJ, Krieg T, Distler J, Distler O.
Rheumatology (Oxford). 2009 Jun;48 Suppl 3:iii3-7. Review.
Collagen V and vascular injury promote lung architectural changes in systemic sclerosis.
Parra ER, Aguiar AC Jr, Teodoro WR, de Souza R, Yoshinari NH, Capelozzi VL.
Clin Respir J. 2009 Jul;3(3):135-42.
[Systemic sclerosis].
Ihn H.
Nihon Rinsho. 2009 Mar;67(3):519-22. Review. Japanese.
The immunobiology of systemic sclerosis.
Gu YS, Kong J, Cheema GS, Keen CL, Wick G, Gershwin ME.
Semin Arthritis Rheum. 2008 Oct;38(2):132-60. Epub 2008 Jan 25. Review.
Genetic factors in systemic sclerosis.
Mayes MD, Trojanowska M.
Arthritis Res Ther. 2007;9 Suppl 2:S5. Review.
Therapeutic targets in systemic sclerosis.
Denton CP.
Arthritis Res Ther. 2007;9 Suppl 2:S6. Review.
Potential benefit of statins for vascular disease in systemic sclerosis.
Kuwana M.
Curr Opin Rheumatol. 2006 Nov;18(6):594-600. Review.
Endothelin receptor antagonism--new perspectives in the treatment of systemic sclerosis.
Kowal-Bielecka O, Sierakowski S.
Rocz Akad Med Bialymst. 2005;50 Suppl 1:291-3. Review.
Systemic sclerosis and infections.
Randone SB, Guiducci S, Cerinic MM.
Autoimmun Rev. 2008 Oct;8(1):36-40. Epub 2008 Aug 13. Review.
Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
Distler JH, Jüngel A, Pileckyte M, Zwerina J, Michel BA, Gay RE, Kowal-Bielecka O, Matucci-Cerinic M, Schett G, Marti HH, Gay S, Distler O.
Arthritis Rheum. 2007 Dec;56(12):4203-15.
Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis.
Koch AE, Distler O.
Arthritis Res Ther. 2007;9 Suppl 2:S3. Review.
Role of endogenous endothelin in endothelial dysfunction in murine model of systemic sclerosis: tight skin mice 1.
Richard V, Solans V, Favre J, Henry JP, Lallemand F, Thuillez C, Marie I.
Fundam Clin Pharmacol. 2008 Dec;22(6):649-55.
Vasoactive therapies in systemic sclerosis.
Riemekasten G, Sunderkötter C.
Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii49-51. Review. Erratum in: Rheumatology (Oxford). 2008 Feb;47(2):234-5.
[Characteristic of the endogenous peptides--endothelins and their role in the connective tissue fibrosis].
Garncarczyk A, Jurzak M, Gojniczek K.
Wiad Lek. 2008;61(4-6):126-34. Review. Polish.
Vascular involvement in systemic sclerosis (SSc).
Kahaleh MB.
Clin Exp Rheumatol. 2004 Jan-Feb;22(3 Suppl 33):S19-23. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on